*Yutaka Fujii^1,2, Satoshi Asakura^3,2, Nobuyuki Mitsui^2,3 (1. Hokkaido prefectural Koyogaoka Hospital, Abasiri, Hokkaido, Japan, 2. Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 3. Health Care Center, Hokkaido University, Sapporo, Hokkaido, Japan)

*Wei-Lieh Huang¹, Shih-Cheng Liao², Chi-Shin Wu³, Yi-Ting Chiu¹ (1. National Taiwan University Hospital Yunlin Branch, 2. National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu Hospital, 3. National Center for Geriatrics and Welfare Research, National Health Research Institutes)

*Rafael Freire^1,2,3, Marcos Fidry³, Morena Zugliani³, Mariana Cabo³, Clara Faria³, Antonio Nardi³ (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil)

Saki Kamiyama¹, *Saeko Ikai-Tani^2,3,4, Mirai So¹, Hiroyuki Uchida² (1. Department of Psychiatry, Tokyo Dental College, Chiba, Japan, 2. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 3. Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada, 4. Department of Psychiatry, Minami-Hanno Hospital, Saitama, Japan)

*NOBUYUKI MITSUI MITSUI¹, Yutaka Fujii², Satoshi Asakura¹, Hissei Imai³, Hisashi Yamada⁴, Naoki Yoshinaga⁵, Yoshihiro Kanai⁶, Takeshi Inoue⁷, Eiji Shimizu⁸ (1. Department of Psychiatry, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan, 2. Department of Psychiatry, Houyougaoka Hospital, Hokkaido, Japan, 3. Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan, 4. Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan, 5. School of Nursing, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, 6. Department of Human Science, Faculty of Liberal Arts, Tohoku Gakuin University, Sendai, Japan, 7. Department of Psychiatry, Tokyo Medical University, Tokyo, Japan, 8. Cognitive Behavioral Therapy Center, Chiba University Hospital, Chiba, Japan)

Sofia Nasini¹, Sara Tidei¹, Benedetta Barzon¹, Sara De Martin¹, Marco Banzato¹, Andrea Mattarei¹, Franco Folli², Marco Pappagallo³, Paolo L Manfredi³, *Stefano Comai¹ (1. University of Padua, 2. University of Milan, 3. Relmada Therapeutics)

Juliana Almeida da Silva¹, Luiz Luciano Falconi-Sobrinho¹, Yara Bezerra de Paiva¹, Rafael Carvalho Almada¹, *Norberto Cysne Coimbra¹ (1. Ribeirão Preto Medical School of the University of São Paulo)

*S Melker Hagsäter¹, Robert Pettersson¹, Daniela Anatasovski¹, Elias Eriksson (1. Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg)

*Yi Li¹, Dong-Dong Shi^1,2, Zhen Wang^1,2,3 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2. Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 3. Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China)

*Ying-Dan Zhang¹, Dong-Dong Shi^1,2, Sen Zhang², Zhen Wang^1,2,3 (1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., 2. Shanghai Key Laboratory of Psychotic disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., 3. Institute of Psychological and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China)

*Hiroko Ikeda¹, Aimi Yamagishi¹, Naomi Yonemochi¹ (1. Hoshi University School of Pharmacy and Pharmaceutical Sciences)

*Karin Nakahara¹, Akihiro Mouri^1,2, Kazuo Kunisawa¹, Masaya Hasegawa¹, Toshitaka Nabeshima^2,3 (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan. , 3. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan.)

*Chihiro Nozaki¹, Kaede Ito², Shigenobu Shibata³ (1. Global Center for Science and Engineering, Waseda University, Tokyo, Japan, 2. Department of Advanced Science and Engineering, Waseda University, Tokyo, Japan, 3. Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)

*Yurie Nakamoto¹, Mio Kaga², Seiji Kawana², Kazuhiko Nakamura³, Kazutaka Ikeda¹, Mitsunobu Yoshii¹ (1. Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo Japan, 2. Department of Dermatology, Nippon Medical School, Tokyo, Japan, 3. Department of Neuropsychiatry, Hirosaki University School of Medicine, Aomori, Japan)

*Raul Andero¹ (1. Autonomous University of Barcelona)